The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by ...

The cholesterol-lowering medication alirocumab, a PCSK9 inhibitor, along with a statin, lowered LDL cholesterol levels more than 50% in patients after a heart transplant, compared to those taking a ...

Some bacterial species, particularly some linked to inflammation, are associated with coronary artery disease, a common form ...

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...

Black cumin, or Nigella sativa, is a traditional remedy now scientifically recognized for supporting heart health. Its ...

A new study found that your score on a key cardiovascular test may indicate your risk of dying in the coming years — even ...

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...

The motive behind the CARDIA study is simply to see how daily dairy intake in early adulthood can be linked to coronary ...

A new experimental pill reduces bad cholesterol levels by up to 60 per cent, sparking hopes of a breakthrough in heart disease prevention. Researchers say the drug could be a game-changer for patients ...